Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis

NCT04502381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Mucormycosis

Interventions

DRUG: Inhaled amp B deoxycholate+intravenous liposomal amp B
DRUG: Intravenous liposomal amphotericin B alone

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh